The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

Michael J. Lipinski, Umberto Benedetto, Ricardo O. Escarcega, Giuseppe Biondi-Zoccai, Thibault Lhermusier, Nevin C. Baker, Rebecca Torguson, H. Bryan Brewer Jr, Ron Waksman
  • European Heart Journal, November 2015, European Society of Cardiology
  • DOI: 10.1093/eurheartj/ehv563

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof. Giuseppe Biondi-Zoccai